Faculty

Institution

Unit

Venue

Kapusta, Daniel R

Louisiana State University Health Sciences Center, New Orleans

Affiliations

School of Medicine

Department Of Pharmacology

Louisiana State University Health Sciences Center, New Orleans

NoneKapusta, Daniel R is currently serving as a Pharmacology faculty at Louisiana State University Health Sciences Center, New Orleans.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Kapusta, Daniel R

Louisiana State University Health Sciences Center, New Orleans

You can click a keyword to filter the displayed items

physiology pharmacology neuroscience nephrology cardiovascular research circulatory physiology hypertension neuropharmacology receptors renal function endocrinology molecular pharmacology molecular physiology neurology pharmacological research neuropsychopharmacology addiction biology neurophysiology renal pathophysiology cardiology mammalian biology vascular biology blood pressure radiofrequency renal denervation psychoneuroendocrinology mammalian physiology animal physiology pain medicine pain research cardiovascular pharmacology peptides protein science peptide science neurochemistry thrombosis energy homeostasis comparative physiology human physiology veterinary physiology functional selectivity brain function cellular neurobiology physiological regulation mechanisms of action molecular regulation renal sympathetic denervation hypothalamic paraventricular nucleus hyperlipidemia pulmonary arterial hypertension acute kidney injury cytokines nitrosative stress blood flow natural convection brain mechanisms physiological research neuroprotection adrenal disease receptor (biochemistry) epigenetic changes viral genetics transcription regulation rna biology kidney injury potential role uric acid renin-angiotensin system neprilysin activity cytokine blockade novel potent mouse hypothalamus orexigenic neuropeptide expression ischemic heart salt resistance fluid retention salt-sensitive rats

Notable Scholarly Works

Notable Federal Grants

Collaborators

Renal Tubule Cell-Specific Npr1 is Essential to Regulate Blood Pressure and Kidney Dysfunction. Hypertension (2026)

Central Inhibition of Antidiuretic Hormone by the Kappa Opioid Receptor Agonist Nalfurafine Prevents and Reverses Loop Diuretic Resistance. Physiology (2024)

receptorsdrug metabolismcirculatory physiologypharmacological researchneuropharmacologyendocrinologyhypertensionpharmacologyapplied pharmacologyphysiologymolecular pharmacologyanesthesiologydrug discoverypharmacotherapyneuropsychopharmacologymolecular physiologyaddiction biology

Combination Treatment of Difelikefalin and Tolvaptan for Late-Stage Polycystic Kidney Disease. Journal of the American Society of Nephrology (2024)

Early Renal Denervation Attenuates Cardiac Dysfunction in Heart Failure With Preserved Ejection Fraction. Journal of the American Heart Association (2024)

Epigenetic Mechanisms Differentially Regulate Blood Pressure and Renal Dysfunction in Male and Female Npr1 Haplotype Mice. The FASEB Journal (2024)

Prerna KumarKandasamy NeelamegamChandramohan RamasamyRamachandran SamivelHuijing XiaDaniel R. KapustaKailash N. Pandey

epigeneticsgeneticsrenal dysfunctionepigenetic mechanismsepigenetic changes

Podocyte Cell-Specific Npr1 is Required for Blood Pressure and Renal Homeostasis in Male and Female Mice: Role of Sex-Specific Differences. Physiological Genomics (2024)

chandramohan RamasamyKandasamy NeelamegamSamivel RamachandranHuijing XiaDaniel R. KapustaFarhad R. DaneshKailash N. Pandey

genomicssex-specific differencesphysiologyrenal homeostasis

Prevention and Reversal of Furosemide-Induced Diuretic Resistance Using the Kappa Opioid Receptor Agonist Nalfurafine. The American Journal of the Medical Sciences (2024)

364 Beneficial Actions of Sglt2 Inhibition and H2S Therapy in Heart Failure With Preserved Ejection Fraction. Journal of Clinical and Translational Science (2023)

circulatory physiologysglt2 inhibitioncardiologycardiovascular functionheart failurepharmacologyh2s therapyphysiologycritical carecardiovascular researchcardiovascular pharmacology

New Therapy for Early-Stage Polycystic Kidney Disease: Combination of Difelikefalin and Tolvaptan. Journal of the American Society of Nephrology (2023)

Treatment of Diuretic Resistance With a Kappa Opioid Agonist, an Inhibitor of Central Vasopressin Secretion. Journal of the American Society of Nephrology (2023)

Ashlyn Y. AndersonJuan GaoKara JohnsonIan B. DenysLuke E. BeckendorfJacob K. MearimanDaniel R. Kapusta

medicinediuretic resistancecentral vasopressin secretionpharmacologykappa opioid agonistnephrology

1
2
3
4
5
13
10 / page

Kapusta, Daniel R

Louisiana State University Health Sciences Center, New Orleans

Affiliations

School of Medicine

Department Of Pharmacology

Louisiana State University Health Sciences Center, New Orleans

NoneKapusta, Daniel R is currently serving as a Pharmacology faculty at Louisiana State University Health Sciences Center, New Orleans.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Kapusta, Daniel R

Louisiana State University Health Sciences Center, New Orleans

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Renal Tubule Cell-Specific Npr1 is Essential to Regulate Blood Pressure and Kidney Dysfunction. Hypertension (2026)

Central Inhibition of Antidiuretic Hormone by the Kappa Opioid Receptor Agonist Nalfurafine Prevents and Reverses Loop Diuretic Resistance. Physiology (2024)

Combination Treatment of Difelikefalin and Tolvaptan for Late-Stage Polycystic Kidney Disease. Journal of the American Society of Nephrology (2024)

Early Renal Denervation Attenuates Cardiac Dysfunction in Heart Failure With Preserved Ejection Fraction. Journal of the American Heart Association (2024)

Epigenetic Mechanisms Differentially Regulate Blood Pressure and Renal Dysfunction in Male and Female Npr1 Haplotype Mice. The FASEB Journal (2024)

Prerna KumarKandasamy NeelamegamChandramohan RamasamyRamachandran SamivelHuijing XiaDaniel R. KapustaKailash N. Pandey

epigeneticsgeneticsrenal dysfunctionepigenetic mechanismsepigenetic changes

Podocyte Cell-Specific Npr1 is Required for Blood Pressure and Renal Homeostasis in Male and Female Mice: Role of Sex-Specific Differences. Physiological Genomics (2024)

chandramohan RamasamyKandasamy NeelamegamSamivel RamachandranHuijing XiaDaniel R. KapustaFarhad R. DaneshKailash N. Pandey

genomicssex-specific differencesphysiologyrenal homeostasis

Prevention and Reversal of Furosemide-Induced Diuretic Resistance Using the Kappa Opioid Receptor Agonist Nalfurafine. The American Journal of the Medical Sciences (2024)

364 Beneficial Actions of Sglt2 Inhibition and H2S Therapy in Heart Failure With Preserved Ejection Fraction. Journal of Clinical and Translational Science (2023)

circulatory physiologysglt2 inhibitioncardiologycardiovascular functionheart failurepharmacologyh2s therapyphysiologycritical carecardiovascular researchcardiovascular pharmacology

New Therapy for Early-Stage Polycystic Kidney Disease: Combination of Difelikefalin and Tolvaptan. Journal of the American Society of Nephrology (2023)

Treatment of Diuretic Resistance With a Kappa Opioid Agonist, an Inhibitor of Central Vasopressin Secretion. Journal of the American Society of Nephrology (2023)

Ashlyn Y. AndersonJuan GaoKara JohnsonIan B. DenysLuke E. BeckendorfJacob K. MearimanDaniel R. Kapusta

medicinediuretic resistancecentral vasopressin secretionpharmacologykappa opioid agonistnephrology

1
2
3
4
5
13
10 / page